1<\/sup>, Grup per l\u2019Estudi dels Limfomes de Catalunya i Balears (GELCAB)<\/p>\n","protected":false},"excerpt":{"rendered":"Alexandra Valera,1\u00a0Armando L\u00f3pez-Guillermo,1\u00a0Teresa Cardesa-Salzmann,1\u00a0Fina Climent,2\u00a0Eva Gonz\u00e1lez-Barca,3\u00a0Santiago Mercadal,3\u00a0\u00cd\u00f1igo Espinosa,4\u00a0Silvana Novelli,4\u00a0Javier Briones,4\u00a0Jos\u00e9 L. Mate,5\u00a0Olga Salamero,5\u00a0Juan M. Sancho,5\u00a0Leonor Arenillas,6\u00a0Sergi Serrano,6\u00a0Nadina Erill,7\u00a0Daniel Mart\u00ednez,1\u00a0Paola Castillo,1\u00a0Jordina Rovira,1\u00a0Antonio Mart\u00ednez,1\u00a0Elias Campo,1\u00a0and\u00a0Luis Colomo1, Grup per l\u2019Estudi dels Limfomes de Catalunya i Balears (GELCAB)<\/p>\n","protected":false},"template":"","class_list":["post-3059","articulo","type-articulo","status-publish","hentry"],"acf":[],"yoast_head":"\n
MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy - Atrys Health<\/title>\n<meta name=\"description\" content=\"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.atryshealth.com\/es\/articulo\/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy - Atrys Health\" \/>\n<meta property=\"og:description\" content=\"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.atryshealth.com\/es\/articulo\/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Atrys Health\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-21T07:53:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.atryshealth.com\/wp-content\/uploads\/2021\/12\/atrys-logo-probar-web.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1563\" \/>\n\t<meta property=\"og:image:height\" content=\"1014\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Atrys_Health\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/articulo\\\/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy\\\/\",\"url\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/articulo\\\/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy\\\/\",\"name\":\"MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy - Atrys Health\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#website\"},\"datePublished\":\"2021-09-21T07:53:47+00:00\",\"dateModified\":\"2021-09-21T07:53:57+00:00\",\"description\":\"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/articulo\\\/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/articulo\\\/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/articulo\\\/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Art\u00edculos y patentes\",\"item\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/articulo\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/\",\"name\":\"Atrys Health\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#organization\",\"name\":\"Atrys Health S.A.\",\"url\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.atryshealth.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/atrys-logo-probar-web.png\",\"contentUrl\":\"https:\\\/\\\/www.atryshealth.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/atrys-logo-probar-web.png\",\"width\":1563,\"height\":1014,\"caption\":\"Atrys Health S.A.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.atryshealth.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/Atrys_Health\",\"https:\\\/\\\/es.linkedin.com\\\/company\\\/atrys-health\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCejhA_ghBXRG1xoe9HB9pEw\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy - Atrys Health","description":"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.atryshealth.com\/es\/articulo\/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy\/","og_locale":"es_ES","og_type":"article","og_title":"MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy - Atrys Health","og_description":"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.","og_url":"https:\/\/www.atryshealth.com\/es\/articulo\/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy\/","og_site_name":"Atrys Health","article_modified_time":"2021-09-21T07:53:57+00:00","og_image":[{"width":1563,"height":1014,"url":"https:\/\/www.atryshealth.com\/wp-content\/uploads\/2021\/12\/atrys-logo-probar-web.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@Atrys_Health","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.atryshealth.com\/es\/articulo\/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy\/","url":"https:\/\/www.atryshealth.com\/es\/articulo\/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy\/","name":"MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy - Atrys Health","isPartOf":{"@id":"https:\/\/www.atryshealth.com\/es\/#website"},"datePublished":"2021-09-21T07:53:47+00:00","dateModified":"2021-09-21T07:53:57+00:00","description":"Somos una gran compa\u00f1\u00eda. Creamos nuevas soluciones para los pacientes y el sector sanitario. Miles de profesionales de Atrys ponemos nuestra experiencia al servicio de todos, para ofrecer diagn\u00f3sticos y tratamientos de precisi\u00f3n.","breadcrumb":{"@id":"https:\/\/www.atryshealth.com\/es\/articulo\/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.atryshealth.com\/es\/articulo\/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.atryshealth.com\/es\/articulo\/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.atryshealth.com\/es\/"},{"@type":"ListItem","position":2,"name":"Art\u00edculos y patentes","item":"https:\/\/www.atryshealth.com\/es\/articulo\/"},{"@type":"ListItem","position":3,"name":"MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy"}]},{"@type":"WebSite","@id":"https:\/\/www.atryshealth.com\/es\/#website","url":"https:\/\/www.atryshealth.com\/es\/","name":"Atrys Health","description":"","publisher":{"@id":"https:\/\/www.atryshealth.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.atryshealth.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.atryshealth.com\/es\/#organization","name":"Atrys Health S.A.","url":"https:\/\/www.atryshealth.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.atryshealth.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.atryshealth.com\/wp-content\/uploads\/2021\/12\/atrys-logo-probar-web.png","contentUrl":"https:\/\/www.atryshealth.com\/wp-content\/uploads\/2021\/12\/atrys-logo-probar-web.png","width":1563,"height":1014,"caption":"Atrys Health S.A."},"image":{"@id":"https:\/\/www.atryshealth.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/Atrys_Health","https:\/\/es.linkedin.com\/company\/atrys-health","https:\/\/www.youtube.com\/channel\/UCejhA_ghBXRG1xoe9HB9pEw"]}]}},"_links":{"self":[{"href":"https:\/\/www.atryshealth.com\/es\/wp-json\/wp\/v2\/articulo\/3059","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atryshealth.com\/es\/wp-json\/wp\/v2\/articulo"}],"about":[{"href":"https:\/\/www.atryshealth.com\/es\/wp-json\/wp\/v2\/types\/articulo"}],"wp:attachment":[{"href":"https:\/\/www.atryshealth.com\/es\/wp-json\/wp\/v2\/media?parent=3059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}